col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


33 Results       Page 1

 [1] 
Case Western Reserve University: Pathogens and Immunity
  original article Date Title Authors   All Authors
1 [GO] 2026―May―06 Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19 Evelyn Kung, Rinki Deo, Manish C. Choudhary, Kara W. Chew, Teresa H. Evering, Rachel Bender Ignacio, et al. (+18)
2 [GO] 2026―Feb―16 A Novel Adaptive Platform for Rapid, Simple Flow-Based Antibody Detection Devices Predicts NAb Levels to SARS-CoV-2 Andreas Markmann, D. Ryan Bhowmik, Baowei Jiang, Usaphea Vanna, Michael Van Hoy, Frank Wang, et al. (+5)
3 [GO] 2025―Jul―09 Investigating the Interplay of SARS-CoV-2 RNAemia and Peripheral Inflammation in Platelet Dysfunction During Acute SARS-CoV-2 Infection Mariangela Scavone, Roberta Rovito, Claudia Ghali, Antonella Fioretti, Bianca Clerici, Elena Bossi, et al. (+5)
4 [GO] 2025―May―22 Development and Concordance of Binding and Neutralizing Assays to Determine SARS-CoV-2 Antibody Activity in Human Milk Mallory C. Shriver, Patricia L. Milletich, Alberto Moreno, Sasha E. Larsen, Christine M. Posavad, Bryan J. Berube, et al. (+13)
5 [GO] 2025―May―15 Protection of Prior SARS-CoV-2 Infection Against Different Variants, Including Omicron Descendants, in a Country with High Viral Transmission Stefan Escobar-Agreda, Roger Araujo-Castillo, Luis Pampa-Espinoza, Javier Silva-Valencia, Lely Solari
6 [GO] 2024―Oct―02 Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP.3.3 From Approved Monoclonal Antibodies Delphine Planas, Isabelle Staropoli, Cyril Planchais, Emilie Yab, Banujaa Jeyarajah, Yannis Rahou, et al. (+8)
7 [GO] 2024―Aug―22 Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response Marc-Kendy Paul, Manish Choudhary, Amy Heaps, Rinki Deo, Daniela Moisi, Kelley Gordon, et al. (+11)
8 [GO] 2024―Jun―19 Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2 Ruth Connor, Mrunal Sakharkar, Garrett Rappazzo, Chengzi Kaku, Nicholas Curtis, Seungmin Shin, et al. (+8)
9 [GO] 2024―Apr―24 Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Among Residents and Employees in a Veterans Affairs Community Living Center: A 42-Month Prospective Cohort Study Chetan Jinadatha, Lucas Jones, Jennifer Hailes, Emma Marshall, Munok Hwang, Jennifer Cadnum, et al. (+7)
10 [GO] 2024―Feb―12 Replication and Injury Associated With SARS-CoV-2 in Cultured Hepatocytes Suman Pradhan, Susan D. Rouster, Jason T. Blackard, Gary E. Dean, Kenneth E. Sherman
11 [GO] 2024―Feb―07 Stable Levels of Antibodies Against Unrelated Toxoid Vaccines After COVID-19: COVID-19 Infection Does Not Affect Toxoid Vaccine Antibody Levels Suvi T. Jokiranta, Simo Miettinen, Sami Salonen, Lauri Kareinen, Ruut Uusitalo, Essi M. Korhonen, et al. (+11)
12 [GO] 2023―Dec―21 Arterial Stiffness and Oxidized LDL Independently Associated With Post-Acute Sequalae of SARS-CoV-2 Sokratis Zisis, Jared Durieux, Christian Mouchati, Nicholas Funderburg, Kate Ailstock, Mary Chong, et al. (+2)
13 [GO] 2023―Nov―18 Dynamics of T-cell Responses Following COVID-19 mRNA Vaccination and Breakthrough Infection in Older Adults Sneha Datwani, Rebecca Kalikawe, Francis Mwimanzi, Sarah Speckmaier, Richard Liang, Yurou Sang, et al. (+11)
14 [GO] 2023―Jun―27 Immunohematologic Biomarkers in COVID-19: Insights into Pathogenesis, Prognosis, and Prevention David Sweet, Michael Freeman, David Zidar
15 [GO] 2023―Feb―21 Immune Dysregulation in Acute SARS-CoV-2 Infection Lauren Grimm, Chinyere Onyeukwu, Grace Kenny, Danielle Parent, Jia Fu, Shaurya Dhingra, et al. (+5)
16 [GO] 2022―Dec―11 Evaluation of Interventions to Improve Ventilation in Households to Reduce Risk for Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Wilson Ha, Mitchell Stiefel, Jeremy Gries, Jennifer Cadnum, Maria Torres-Teran, Brigid Wilson, Curtis Donskey
17 [GO] 2022―Dec―10 B-Cell Responses to Sars-Cov-2 mRNA Vaccines Lela Kardava, Clarisa Buckner, Susan Moir
18 [GO] 2022―Nov―11 Pandemics and the English Language: Concepts Critical for Conversing About COVID-19 Neil S. Greenspan, Guillermo A. Pereda
19 [GO] 2022―Aug―23 An ACE2-IgG4 Fc Fusion Protein Demonstrates Strong Binding to All Tested SARS-CoV-2 Variants and Reduced Lung Inflammation in Animal Models of SARS-CoV-2 and Influenza Emmanuel Merigeon, Dong Yang, Elizabeth Ihms, Leda Bassit, Elizabeth Fitzpatrick, Colleen Jonsson, et al. (+3)
20 [GO] 2022―Jun―25 Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies Michael Peluso, Khamal Anglin, Matthew S. Durstenfeld, Jeffrey N. Martin, J. Daniel Kelly, Priscilla Y. Hsue, et al. (+2)
21 [GO] 2022―May―03 Erica Ollmann Saphire: How the Study of HIV and Other Viruses Informed the Rapid Development of Vaccines and Therapeutic Antibodies Against COVID-19 Neil S. Greenspan
22 [GO] 2021―Nov―12 Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA Level Shay Leary, Silvana Gaudieri, Matthew Parker, Abha Chopra, Ian James, Suman Pakala, et al. (+14)
23 [GO] 2021―Nov―05 Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2 Nurit P Azouz, Andrea Klingler, Victoria Callahan, Ivan Akhrymuk, Katarina Elez, Lluís Raich, et al. (+6)
24 [GO] 2021―Jul―19 Molecular Diagnosis of SARS-CoV-2: Assessing and Interpreting Nucleic Acid and Antigen Tests Peter Zimmerman, Christopher King, Mahmoud Ghannoum, Robert Bonomo, Gary Procop
25 [GO] 2021―Jun―07 Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva Thomas J. Ketas, Devidas Chaturbhuj, Victor M. Cruz Portillo, Erik Francomano, Encouse Golden, Sharanya Chandrasekhar, et al. (+14)
26 [GO] 2021―May―15 COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review Jessica Jones, Aiman Faruqi, James Sullivan, Cassandra Calabrese, Leonard Calabrese
27 [GO] 2021―Mar―09 The intersection of COVID-19 and autoimmunity: What is our current understanding? Nicole Eve Winchester, Cassandra Calabrese, Leonard Calabrese
28 [GO] 2020―Oct―21 Anisocytosis is Associated With Short-Term Mortality in COVID-19 and May Reflect Proinflammatory Signature in Uninfected Ambulatory Adults Andrew Hornick, Nour Tashtish, Michael Osnard, Binita Shah, Allison Bradigan, Zainab Albar, et al. (+8)
29 [GO] 2020―Oct―21 The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET Sunil Thomas
30 [GO] 2020―Oct―02 Temporal Clinical and Laboratory Response to Interleukin-6 Receptor Blockade With Tocilizumab in 89 Hospitalized Patients With COVID-19 Pneumonia Daria Fomina, Mar’yana A. Lysenko, Irina P. Beloglazova, Zinaida Yu. Mutovina, Nataliya G. Poteshkina, Inna V. Samsonova, et al. (+3)
31 [GO] 2020―Oct―01 Anisocytosis is Associated With Short-Term Mortality in COVID-19 and May Reflect Proinflammatory Signature in Uninfected Ambulatory Adults Andrew Hornick, Nour Tashtish, Michael Osnard, Binita Shah, Allison Bradigan, Zainab Albar, et al. (+8)
32 [GO] 2020―May―23 Evaluation of Ultraviolet-C Light for Rapid Decontamination of Airport Security Bins in the Era of SARS-CoV-2 Jennifer Cadnum, Daniel F. Li, Lucas D. Jones, Sarah N. Redmond, Basya Pearlmutter, Brigid Wilson, Curtis J. Donskey
33 [GO] 2020―May―23 Characteristic Temporary Loss of Taste and Olfactory Senses in SARS-CoV-2-positive-Individuals with Mild Symptoms Ricarda Maria Schmithausen, Manuel Döhla, Heidrun Schößler, Christin Diegmann, Bianca Schulte, Enrico Richter, et al. (+2)
 [1] 

33 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.007 sec